Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Earnings release
confidence 75%
filed 2026-06-30
EX-99.1
This is a clinical trial data announcement press release disclosing interim 12-month results from the Phase 1b/2 ABATE trial of ACI-24. While not traditional financial earnings, the disclosure of clinical trial progress, safety data, and dose-response results for a lead therapeutic candidate is material to investors in a clinical-stage biopharmaceutical company. The announcement also references a $12 million milestone payment from Takeda triggered by dosing in Cohort AD4, which is a material financial event. The press release format and disclosure of interim trial results align with how clinical-stage biotech companies communicate material operational and financial developments to investors.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-06-30
EX-99.1
This news release announces the mailing of a Letter of Transmittal in connection with a previously-announced "merger of equals" between Teck Resources Limited and Anglo American plc under a court-approved plan of arrangement. The disclosure details the mechanics of the share exchange (1.3301 Anglo Shares per Teck Share) and settlement procedures for shareholders. This is a material M&A completion event—the operative step in executing a major business combination that would fundamentally alter Teck's corporate structure and ownership.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-30
Item 5.07
This Item 5.07 disclosure reports the complete voting results from NVIDIA's June 24, 2026 Annual Meeting of Stockholders, including election of ten directors, advisory vote on named executive officer compensation, ratification of PricewaterhouseCoopers LLP as auditor, and four stockholder proposals. The filing directly matches the shareholder_vote_results event type, which covers results of votes at annual or special meetings of security holders. The outcomes are material to investors as they confirm board composition, executive compensation approval, and auditor selection.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-30
Item 8.01
Ingredion completed the sale of a 51% stake in Rafhan Maize Products Co. Ltd. to the Nishat Group for approximately $165 million in cash. This constitutes a material disposition of a significant subsidiary that generated approximately $250 million in net sales in 2025. The transaction involves a change in control of a substantial operating asset and is disclosed under Item 8.01 as a completed material transaction.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 92%
filed 2026-06-30
Item 8.01
Eagle Bancorp disclosed settlement of a U.S. Attorney's Office investigation into anti-money laundering controls and a customer relationship involving bank fraud, with a one-year non-prosecution agreement and $9.8 million payment. This is a material regulatory settlement and resolution of a government investigation that would significantly affect a reasonable investor's assessment of the company's compliance posture and financial obligations.
View raw filing on EDGAR →
6-K
M&A activity
confidence 99%
filed 2026-06-30
EX-99.1
This is a Material Change Report (Form 51-102F3) disclosing the closing of Hudbay's acquisition of Arizona Sonoran Copper Company Inc. via court-approved plan of arrangement on June 24, 2026. Arizona Sonoran is now a wholly-owned subsidiary, with former shareholders receiving 0.242 Hudbay shares per Arizona Sonoran share, and 46.8 million Hudbay shares issued as consideration. This is a completed material acquisition that would materially affect a reasonable investor's assessment of Hudbay.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-30
Item 2.03
HIVE Digital Technologies issued $130 million aggregate principal amount of 0% exchangeable senior notes due 2031 on June 30, 2026, through its wholly-owned Bermuda subsidiary with a full guarantee from HIVE. The notes are exchangeable into common shares at an initial exchange price of approximately $4.83 per share, with up to 26.9 million shares potentially issuable upon exchange, representing a material debt issuance with significant equity dilution potential.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-30
EX-99.1
This press release announces Largo's award of a five-year U.S. Department of Defense contract to supply up to 2,876 metric tonnes of high-purity vanadium pentoxide with a maximum value of US$125 million. While the contract itself is a material operational and commercial milestone—establishing Largo as an approved supplier to the DLA and positioning it within the U.S. defense industrial base—it does not fit the specific categories of M&A activity, debt issuance, or other named event types. The disclosure emphasizes strategic positioning, supply chain security, and expected improvements to price realizations, making it a significant operational/commercial event material to investors, but best classified as an operational milestone rather than a discrete financial or governance event.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-30
EX-99.1
The exhibit discloses voting results from NexGen's annual general and special meeting of shareholders held on June 30, 2026, including the election of all nine board director nominees, appointment of PWC LLP as auditors (99.94% in favour), setting the board size at nine directors (95.01% in favour), and approval of a Shareholder Rights Agreement (98.02% in favour). This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, with detailed voting tallies for each director nominee and other matters voted upon.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-30
Item 1.01
Bakhu Holdings entered into material definitive agreements (MOU on March 17, 2026 and Binding Heads of Agreement on April 7, 2026) with Phytocyte that contemplate a change of control through automatic conversion of convertible promissory notes, resulting in Phytocyte obtaining 70% ownership and voting control of the Company while existing shareholders are diluted to 30% ownership.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 95%
filed 2026-06-30
Item 4.01
The Company's prior independent registered public accounting firm resigned on July 25, 2024 due to a PCAOB inquiry, and Qi CPA LLC was engaged as the new auditor on April 23, 2026 to report on financial statements for fiscal years ending July 31, 2024 and 2025.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-30
Item 5.02
Six officers and directors (Teddy Scott, Mitchel Kahn, Aristotle Popolizio, Peter Whitton, Alvin Sun, and Juan Carlos Garcia La Sienra) resigned in January 2025 due to board deadlock over employment terms, and Efstathios Galazis resigned as sole director and officer on March 18, 2026, representing significant leadership instability and governance disruption.
View raw filing on EDGAR →
8-K
Legal Other
confidence 75%
filed 2026-06-30
Item 8.01
The Company received an SEC inquiry on March 24, 2026 regarding non-compliance and failure to file mandatory periodic reports, with the Company requesting the SEC refrain from revoking its registration under Section 12(j) or suspending trading under Section 12(k), materially threatening the Company's continued listing and public status.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 90%
filed 2026-06-30
EX-99.1
MINISO announced a HK$2 billion share repurchase program authorized by the Board, effective June 30, 2026, for a 12-month period, along with automatic repurchase programs totaling HK$800 million (HK$400 million in Hong Kong plus approximately US$51.3 million on NYSE). The programs represent a significant capital return to shareholders and capital allocation decision affecting the company's capital structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-30
Item 5.02
The Board appointed Matthew Pauls as a Class I director on June 29, 2026, increasing the Board size from seven to eight members. While the disclosure includes compensatory details (stock option grant of 6,000 shares), the principal disclosed action is the appointment of a new director with substantial industry experience in biopharmaceuticals. This is a governance event centered on a person taking a role, making exec_appointment the most salient classification.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-30
EX-99.1
The exhibit announces the completion of a planned CEO transition with two key executive appointments effective July 1, 2026: Ender Özgün as Chief Executive Officer of Hepsiburada with overall company responsibility, and Hakan Karadoğan as CEO of the Delivery business. While Nilhan Gökçetekin's departure is also disclosed, the principal disclosed action is the appointment of new leadership to critical executive roles, making this an exec_appointment event. This is material as it represents a significant change in the company's leadership structure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-30
Item 8.01
This Item 8.01 discloses the final results of tender offers for TopBuild's debt securities and the stockholder election results for merger consideration in connection with QXO's acquisition of TopBuild. The filing announces that 99.54% of the 2032 Notes and 99.75% of the 2034 Notes were tendered, and that TopBuild stockholders elected the form of consideration (91% elected cash, with proration applied). The transaction is expected to close on July 1, 2026. This represents the completion phase of a material acquisition activity.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-30
EX-99.1
This exhibit is a feasibility study announcement for the Diamba Sud Gold Project, disclosing detailed technical and economic parameters (after-tax IRR of 60%, NPV5% of $1 billion, 9.4-year mine life, 116,000 oz/year average production) and advancing the project toward a final investment decision. While it contains financial projections, it is fundamentally an operational/strategic milestone—the completion of a major development study for a material growth project that supports Fortuna's plan to increase annual gold production by ~60% to over 500,000 ounces by 2028. This is a discrete operational event (feasibility study completion and advancement toward FID), not a periodic financial report or earnings release.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-06-30
EX-99.1
LightInTheBox announced on June 26, 2026 that it has regained compliance with NYSE continued listing standards under Section 802.01B after receiving a "below criteria" notice on December 26, 2024 due to insufficient market capitalization and stockholders' equity. The company was granted an 18-month cure period on May 13, 2025, and has now demonstrated compliance. This is a material delisting-risk resolution—the company was previously at risk of delisting and has now cured the deficiency.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 92%
filed 2026-06-30
The 6-K furnishes exhibits incorporating forms of senior notes (4.657% due 2031 and 5.089% due 2036) by reference into a Form F-3 registration statement filed June 18, 2026. This is a debt issuance disclosure under Item 2.03 equivalent, evidencing Sony's creation of new direct financial obligations through a registered public offering of senior notes.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 95%
filed 2026-06-30
Sony announced the granting of restricted stock units (RSUs) to directors, corporate executive officers, other officers, and employees across four series (Twentieth through Twenty-Third). The disclosure details vesting conditions, recipient categories, and share counts (totaling approximately 2.9 million shares across all series). This is a compensatory arrangement for named executives and employees under Sony's stock compensation plan, falling squarely within exec_compensation. The materiality is high given the scale of equity grants to senior leadership and the broad employee base affected.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-30
Item 5.07
This Item 5.07 disclosure reports the results of Sterling Real Estate Trust's annual shareholder meeting held on June 25, 2026, including the election of nine trustees and ratification of RSM US, LLP as the independent auditor. The filing presents vote tallies (For, Withheld, Broker Non-Vote) for each trustee nominee and aggregate voting results for the auditor ratification, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-30
Item 8.01
The filing discloses a declaration of dividends to Series II and Series III Class B Convertible Preferred Stock shareholders in the amounts of $39,050.00 and $18,561.25, respectively, with payment scheduled for July 20, 2026. This is a straightforward dividend distribution event announced via press release on June 30, 2026, and is material as it represents a distribution to shareholders.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 92%
filed 2026-06-30
The 6-K discloses SEK's issuance of US$300,000,000 aggregate principal amount of Medium-Term Notes, Series H, Floating Rate Notes due November 21, 2029. The filing furnishes legal opinions from Swedish and U.S. counsel relating to this debt issuance, which is a material creation of a direct financial obligation. This is a discrete debt-issuance event, not a periodic report.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-30
EX-99.1
This press release provides a material operational update on the Mesabi Metallics project, a key asset underlying TMCR's royalty investment. The disclosure reports that EPC is 95.5% complete with commissioning targeted for August 2026, mechanical completions are advancing across equipment, and the project remains on track. While this is not a discrete event like an acquisition or impairment, it is a material operational milestone update on a strategically significant asset that would affect a reasonable investor's assessment of the company's near-term cash flow potential and business execution. The exhibit does not fit neatly into other categories (not earnings, not M&A, not a periodic report) but clearly constitutes material operational disclosure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-30
Item 8.01
The disclosure announces that Columbus Circle Capital Corp. II (SPAC) has entered into a definitive business combination agreement dated June 26, 2026, with Elroy Air, Inc., whereby Merger Sub will merge with Elroy Air, with Elroy Air continuing as a wholly owned subsidiary of the SPAC. This is a material acquisition/merger transaction expected to close in Q4 2026, subject to shareholder approval. Cohen & Co Inc. has a significant interest through its Operating LLC's ownership stake in the Sponsor and is acting as joint financial advisor and co-placement agent, making this a material M&A activity disclosure under Item 8.01.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-06-30
Item 2.02
Pacific Coast Oil Trust issued a press release on June 30, 2026, announcing its monthly net profits interest calculations for April 2026, disclosing operating income, revenues, expenses, and realized prices for its underlying properties. This is a routine monthly financial disclosure typical of royalty trusts, though the filing also contains material adverse information (no distribution, going-concern implications, and pending litigation) that elevates the overall materiality of the disclosure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 98%
filed 2026-06-30
Item 2.03
Public Service Company of New Hampshire issued an additional $200,000,000 aggregate principal amount of 5.35% First Mortgage Bonds, Series X, Due 2033 on June 30, 2026, pursuant to an Underwriting Agreement. This is a straightforward debt issuance creating a direct financial obligation under Item 2.03, bringing total outstanding bonds in this series to $800,000,000. The materiality is clear given the size and nature of the obligation.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-30
Item 5.02
The filing discloses the appointment of Charlie Cole as Chief Executive Officer and Board member effective July 13, 2026, which is the principal action. While Andrew McLean's departure as CEO and Board member is also disclosed, the salient event centers on the new CEO appointment with detailed compensation terms ($1.1M base, $550K signing bonus, $2.5M in equity grants, and $3.025M+ annual LTI). This is a material executive leadership change for the registrant.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 97%
filed 2026-06-30
Item 1.01
W. P. Carey entered into an underwriting agreement on June 29, 2026 to issue $350 million of 5.200% Senior Notes due 2036 in a public offering. The company intends to use proceeds to repay existing 4.250% Senior Notes due October 2026 and for general corporate purposes.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 90%
filed 2026-06-30
Item 2.03
Westrock Coffee closed Amendment No. 6 to its credit agreement on June 30, 2026, extending the maturity date of approximately $361 million of loans and commitments from August 29, 2027 to November 29, 2028. The amendment also modified covenant terms, including a margin reduction, termination of covenant relief, and tightening of the secured net leverage ratio from 5.00x to 4.00x, and added Texas Capital Bank as a new lender to the syndicate.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-30
Item 1.01
Nuvectis entered into an underwriting agreement on June 29, 2026 to conduct a registered public offering of 5,000,000 shares of common stock at $20.00 per share, generating $100 million in gross proceeds (or $115 million if underwriters exercise their 30-day option for 750,000 additional shares), resulting in net proceeds of approximately $93–107 million after underwriting fees.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-30
Item 5.02
The filing discloses the appointment of Margaret M. Weichert to the Board of Directors of Primis Financial Corp. and Primis Bank, effective June 25, 2026, at the recommendation of the Corporate Governance Committee. The prose centers on her election and appointment to the boards and the Corporate Governance Committee, with detailed background on her qualifications. This is a clear executive appointment event material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-06-30
Item 1.01
LTC Properties entered into a Second Amendment to its Credit Agreement on June 26, 2026, increasing the aggregate commitment from $800 million to $1.1 billion and raising total maximum commitments from $1.2 billion to $2.0 billion. The company also entered into interest rate swap agreements to fix rates on $150 million of the facility.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-06-30
Item 4.01
This is a clear auditor change disclosure under Item 4.01. The Company dismissed Deloitte & Touche LLP on June 24, 2026, following a competitive selection process, and appointed BDO USA, P.C. as the new independent registered public accounting firm on June 30, 2026. The filing explicitly states there were no disagreements or reportable events with the prior auditor, indicating a routine transition rather than a dispute-driven change. Auditor changes are material events affecting investor confidence in financial reporting oversight.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-30
Item 7.01
McEwen Inc. announced its addition to the Russell 2000® Index effective June 29, 2026, as disclosed in Item 7.01 (Regulation FD Disclosure). While index inclusion is primarily a market-recognition event rather than a direct operational change, it is material to investors as it increases visibility among institutional investors and index-tracking strategies, potentially affecting stock liquidity and valuation. This is an operational/strategic milestone that does not fit the specific categories of earnings, M&A, executive changes, or financial obligations, making operational_other the most appropriate classification.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-06-30
Item 2.01
Janus Henderson Group PLC completed a take-private merger transaction on June 30, 2026, whereby it was acquired by an investor group led by Trian Fund Management, General Catalyst, and Qatar Investment Authority for $52.00 per share in cash, representing approximately $6.5 billion in aggregate merger consideration. The company became a wholly owned subsidiary, its ordinary shares were delisted from the NYSE, and shareholders' rights were terminated. The transaction was financed in part by a $2.9 billion senior secured term loan credit facility.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-06-30
Item 1.01
The disclosure centers on entry into material supplier agreements for licensing the Company's proprietary software to third parties (Meta Bureau LLC and Progress TRW S.R.O.) for use in unmanned aerial vehicles, generating approximately $3.9 million in initial lump-sum fees plus up to $10.4 million in optional upgrade fees. While this involves contractual arrangements and revenue generation, it does not fit the specific financial categories (debt issuance, dividend, impairment, etc.) or M&A categories, making it a material operational/commercial event—a significant software licensing partnership that would affect investor assessment of the Company's business prospects and revenue streams.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-30
Item 2.02
Eversource Energy completed the sale of Aquarion Water Company to Aquarion Water Authority for $2.4 billion in cash on June 30, 2026, with adjusted net equity proceeds of approximately $1.7 billion to be used to reduce debt. The transaction resulted in an after-tax non-cash charge of approximately $115 million ($0.31 per share) and represents a strategic shift toward a 'pure-play regulated pipes and wires utility,' materially affecting the company's portfolio composition and financial position.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-30
Item 7.01
The disclosure reports regulatory approvals for a material merger between Paramount Skydance Corporation and Warner Bros. Discovery, Inc., pursuant to an Agreement and Plan of Merger dated February 27, 2026. The filing announces unconditional approvals from the Competition Protection Agency of Kuwait (June 28, 2026), the Austrian Federal Competition Authority (June 30, 2026), and the Australian government (June 30, 2026), representing significant progress toward closing a transformative transaction. This is a core M&A activity disclosure under Item 7.01 (Regulation FD Disclosure) that would materially affect investor assessment of the registrant's strategic direction and capital structure.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 98%
filed 2026-06-30
EX-99.1
The Board of Directors of Grupo Financiero Galicia S.A. has resolved to distribute a total cash dividend of $39,999,772,000 to shareholders in three equal installments between July and September 2026, in compliance with resolutions approved at the April 28, 2026 Ordinary Shareholders' Meeting. This is a material dividend distribution that would affect a reasonable investor's assessment of capital allocation and shareholder returns.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 98%
filed 2026-06-30
EX-99.1
The exhibit is a formal notice of cash dividend payment by Grupo Financiero Galicia S.A. declaring a total distribution of Ps. 39,999,772,000 (Ps. 24.9025239772688 per share) to be paid in three equal installments between July and September 2026, authorized by the board on June 30, 2026 pursuant to a shareholders' meeting resolution from April 28, 2026. This is a material capital distribution to shareholders.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 75%
filed 2026-06-30
EX-99.1
The exhibit discloses completion of a tender offer and redemption of senior secured notes due 2028 and 2030, funded by a new debt issuance of $1,100,000,000 of 8.750% Senior Secured Notes due 2032 and $935,000,000 of 9.000% Senior Secured Notes due 2034 (completed June 10, 2026). While the primary event is debt refinancing/restructuring, the creation of new direct financial obligations ($2,035,000,000 in aggregate principal) is the material disclosure. The tender offer and redemption are the mechanism by which old debt is replaced with new debt, making this fundamentally a debt issuance event with material capital structure implications.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-06-30
EX-99.1
The announcement discloses the Board's appointment of Søren Steenberg Jensen, EVP Head of Asset Management, as the successor to CEO Mikael Skov, effective 1 September 2026. While the disclosure also mentions Skov's departure, the principal disclosed action is the appointment of a new CEO to lead the company. This is a material executive succession at the top of the organization affecting investor assessment of leadership continuity and strategy execution.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-06-30
EX-99.1
The exhibit announces the acquisition of two modern-eco Kamsarmax bulk carrier vessels: M/V Magic Saturn (2024-built, $41.9 million purchase price, delivered June 29, 2026) and M/V Magic Jupiter (2023-built, delivered June 29, 2026). These are material acquisitions of operating assets that expand the company's fleet and represent significant capital deployment, funded with cash on hand. This constitutes entry into and completion of material acquisitions under Item 1.01/2.01 of the 8-K taxonomy.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-30
EX-99.1
InflaRx announced it is assessing a broadened development strategy for ANCA-associated vasculitis (AAV) in Europe following the EMA's recommendation to revoke marketing authorization for Tavneos (a competitor product). The company intends to engage with the EMA regarding regulatory pathways for both vilobelimab and izicopan in AAV, representing a material strategic pivot in response to evolving market conditions. This is a significant operational and strategic business development that would affect investor assessment of the company's pipeline and competitive positioning, though it does not fit neatly into discrete event categories like M&A, exec changes, or financial results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-06-30
Item 5.07
Brink's shareholders voted to approve the issuance of Brink's Common Stock in connection with the acquisition of NCR Atleos at a special meeting held on June 30, 2026, with 37,690,024 votes in favor (91.63% quorum representation). Concurrently, NCR Atleos stockholders approved the merger proposal, clearing a critical milestone for the material acquisition transaction.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-30
Item 5.07
NCR Atleos stockholders voted to approve the merger agreement with The Brink's Company at a special stockholder meeting held on June 30, 2026, with 59,403,719 votes in favor (80.70%), 92,237 against, and 63,782 abstentions. This shareholder approval removes a key closing condition for the transformative acquisition.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-06-30
Item 2.03
Vistra Operations amended two credit agreements on June 24, 2026, increasing aggregate revolving credit commitments from $3.44 billion to $5.50 billion, adding $2.06 billion in available liquidity. The amendments also released guarantors from certain obligations, removed collateral reinstatement requirements, and suspended certain covenants, constituting a material restructuring of the company's credit arrangements.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-30
Item 3.02
Tilray issued 2,638,341 shares of common stock in unregistered private debt-for-equity exchange transactions between June 15-24, 2026, exchanging $12 million principal of convertible notes for equity. This is a dilutive issuance of unregistered equity securities under Section 3(a)(9) of the Securities Act, disclosed under Item 3.02, representing material shareholder dilution and a significant capital restructuring event.
View raw filing on EDGAR →